Mount Yale Investment Advisors’s Aurora Cannabis ACB Stock Holding History

Mount Yale Investment Advisors’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$8	–	682
2025 Q2	$8	Buy	+2	New	+$10	﹤0.01%	1491

Other funds holding ACB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Mount Yale Investment Advisors's ACB Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Aurora Cannabis (ACB) in Q3 2025, closing a stake of 2 shares — an estimated $8 sold.

Mount Yale Investment Advisors first reported a position in ACB in Q2 2025 and held it in 1 quarter. The position peaked at $8 in Q2 2025. 164 funds tracked by Wall St. Rank hold ACB as of Q3 2025.

Mount Yale Investment Advisors reported no remaining Aurora Cannabis position as of Q3 2025 after selling out during the quarter.
Mount Yale Investment Advisors sold 2 Aurora Cannabis shares in Q3 2025, an estimated $8.
Mount Yale Investment Advisors first reported a position in Aurora Cannabis in Q2 2025 and held it in 1 quarter.
Mount Yale Investment Advisors's Aurora Cannabis position peaked at $8 in Q2 2025.
164 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.